| Name | Title | Contact Details |
|---|---|---|
Matt Lasmanis |
Chief Information Officer | Profile |
Adam Stein |
Director, Corporate Counsel | Profile |
Nicole Victoria |
Associate Director, Quality Compliance | Profile |
Nicole Victoria |
Associate Director, Quality Compliance | Profile |
William Pezzolo |
Director, Corporate Counsel | Profile |
Quellis was founded to deliver best-in-class therapies to patients suffering serious rare diseases – and underserved by current treatment options. The Company is based in Boston, and is led by partners from the biotech incubator Viridian LLC in collaboration with team at biotech accelerator Xontogeny LLC, and with funding from the Perceptive Xontogeny Venture Fund. The Quellis team has deep experience in mAb discovery and development, company creation, and private and public biotech investment. Our shared goal is to create meaningful medicines for every disease we target.
Palvella Therapeutics was founded with the single-minded goal of serving individuals suffering from serious rare genetic diseases with no approved treatments.
Janssen Research & Development is a Horsham, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Optimer Pharmaceuticals is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
SQZ Biotech is a unique cell therapy company, utilizing the proprietary CellSqueeze® platform to develop a new generation of cell therapies. SQZ currently focuses on the development of novel treatments that leverage targeted immune modulation to impact oncology and autoimmune diseases.